Average Co-Inventor Count = 10.63
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbott Laboratories Corporation (13 from 4,177 patents)
2. Galapagos Nv (12 from 116 patents)
3. Abbvie S.a.r.l. (7 from 15 patents)
4. Abbvie Inc. (5 from 822 patents)
5. Abbvie Overseas Sarl (5 from 5 patents)
6. Abbvie Global Enterprises Ltd. (1 patent)
30 patents:
1. 10988454 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
2. 10981890 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
3. 10844042 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
4. 10844041 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
5. 10829473 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
6. 10428017 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
7. 10399940 - Substituted pyrrolidines and methods of use
8. 10118916 - Modulators of cystic fibrosis transmembrane conductance regulator protein
9. 9981910 - Substituted pyrrolidines and methods of use
10. 9840513 - Substituted tricyclics and method of use
11. 9642831 - Substituted chromanes and method of use
12. 9567322 - Substituted tetrahydropyrans and method of use
13. 8937041 - Macrocyclic hepatitis C serine protease inhibitors
14. 8796470 - Substituted octahydrocyclopenta[c]pyrroles as calcium channel modulators
15. 8691865 - Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers